DOCS - Doximity, Inc.
NYSE
->
Healthcare
->
Health Information Services
San Francisco,
United States
Type: Equity
DOCS price evolution
DOCS
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $111.44 | $96.78 | $123.09 | |
| Short term investments | $639.05 | $666.12 | $587.15 | |
| Net receivables | $130.99 | $128.01 | $101.33 | $97.58 |
| Inventory | ||||
| Total current assets | $957.71 | $908.47 | $912.94 | $840.9 |
| Long term investments | ||||
| Property, plant & equipment | $22.59 | $24.72 | $24.65 | $24.65 |
| Goodwill & intangible assets | $94.2 | $95.26 | $96.32 | |
| Total noncurrent assets | $164.99 | $166.43 | $159.75 | |
| Total investments | $639.05 | $666.12 | $587.15 | |
| Total assets | $1118.52 | $1073.46 | $1079.37 | $1000.65 |
| Current liabilities | ||||
| Accounts payable | $2.77 | $1.66 | $2.25 | $1.88 |
| Deferred revenue | $103.06 | $99.36 | $66.86 | |
| Short long term debt | $2.19 | $2.15 | $2.11 | |
| Total current liabilities | $132.28 | $135.28 | $147.25 | $104.76 |
| Long term debt | $11.84 | $12.4 | $12.95 | |
| Total noncurrent liabilities | $24.6 | $30.73 | $31.27 | |
| Total debt | $14.03 | $14.55 | $15.06 | |
| Total liabilities | $157.32 | $159.88 | $177.98 | $136.03 |
| Shareholders' equity | ||||
| Retained earnings | $95.22 | $72.93 | $79.99 | $61 |
| Other shareholder equity | $2.68 | -$1.01 | -$2.66 | -$4.65 |
| Total shareholder equity | $913.58 | $901.4 | $864.61 | |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $96.78 | $158.03 | $112.81 | $66.39 |
| Short term investments | $666.12 | $682.97 | $685.3 | $76.14 |
| Net receivables | $101.33 | $107.05 | $81.07 | $50.32 |
| Inventory | ||||
| Total current assets | $912.94 | $975.45 | $904.14 | $209.4 |
| Long term investments | ||||
| Property, plant & equipment | $24.65 | $25.1 | $9.57 | $8.94 |
| Goodwill & intangible assets | $95.26 | $99.78 | $26.82 | $28.51 |
| Total noncurrent assets | $166.43 | $161.44 | $87.22 | $42.32 |
| Total investments | $666.12 | $682.97 | $685.3 | $76.14 |
| Total assets | $1079.37 | $1136.89 | $991.36 | $251.72 |
| Current liabilities | ||||
| Accounts payable | $2.25 | $1.27 | $0.46 | $1.51 |
| Deferred revenue | $99.36 | $105.44 | $84.98 | $83.49 |
| Short long term debt | $2.15 | $1.75 | $0.64 | $0.97 |
| Total current liabilities | $147.25 | $139.51 | $111.28 | $102.04 |
| Long term debt | $12.4 | $13.88 | $0.45 | $0.28 |
| Total noncurrent liabilities | $30.73 | $31.27 | $1.48 | $1.48 |
| Total debt | $14.55 | $15.64 | $1.09 | $1.25 |
| Total liabilities | $177.98 | $170.77 | $112.76 | $103.52 |
| Shareholders' equity | ||||
| Retained earnings | $79.99 | $217.85 | $191.11 | $36.32 |
| Other shareholder equity | -$2.66 | -$14.08 | -$15.29 | -$0.02 |
| Total shareholder equity | $901.4 | $966.12 | $878.59 | $66.74 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $136.83 | $118.06 | $135.28 | |
| Cost of revenue | $12.57 | $12.19 | ||
| Gross Profit | $123.16 | $105.49 | $123.09 | |
| Operating activities | ||||
| Research & development | $20.15 | $19.95 | ||
| Selling, general & administrative | $43.49 | $44.6 | ||
| Total operating expenses | $67.71 | $63.64 | $64.54 | |
| Operating income | $41.85 | $58.55 | ||
| Income from continuing operations | ||||
| EBIT | $47.95 | $63.03 | ||
| Income tax expense | $18.02 | $7.33 | $15.08 | |
| Interest expense | $9.14 | |||
| Net income | ||||
| Net income | $44.15 | $40.62 | $47.96 | |
| Income (for common shares) | $40.62 | $47.96 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $475.42 | $419.05 | $343.55 | $206.9 |
| Cost of revenue | $50.67 | $53.49 | $39.79 | $31.2 |
| Gross Profit | $424.75 | $365.56 | $303.76 | $175.7 |
| Operating activities | ||||
| Research & development | $81.98 | $80.19 | $62.35 | $43.87 |
| Selling, general & administrative | $170.96 | $160.27 | $127.88 | $78.53 |
| Total operating expenses | $260.88 | $240.45 | $190.22 | $122.4 |
| Operating income | $163.88 | $125.11 | $113.54 | $53.3 |
| Income from continuing operations | ||||
| EBIT | $185.2 | $133.16 | $114 | $57.77 |
| Income tax expense | $37.62 | $20.34 | -$40.78 | $7.56 |
| Interest expense | ||||
| Net income | ||||
| Net income | $147.58 | $112.82 | $154.78 | $50.21 |
| Income (for common shares) | $147.58 | $112.82 | $133.26 | $21.56 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $41.38 | $40.62 | $47.96 | |
| Operating activities | ||||
| Depreciation | $3.04 | $3.02 | $3.03 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $17.09 | $11.86 | $11.77 | |
| Total cash flows from operations | $41.24 | $63.94 | $50.05 | |
| Investing activities | ||||
| Capital expenditures | -$1.7 | -$1.63 | -$1.32 | |
| Investments | $31.64 | -$74.54 | $41.46 | |
| Total cash flows from investing | $54.1 | $29.94 | -$76.17 | $40.13 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$48.66 | -$12.65 | -$74.25 | |
| Net borrowings | ||||
| Total cash flows from financing | -$76.22 | -$56.53 | -$14.08 | -$75.5 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $87.46 | $14.66 | -$26.3 | $14.69 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $147.58 | $112.82 | $154.78 | $50.21 |
| Operating activities | ||||
| Depreciation | $12.34 | $12.31 | $6.2 | $6.13 |
| Business acquisitions & disposals | -$53.5 | -$27.45 | ||
| Stock-based compensation | $51.08 | $47.83 | $31.44 | $7.25 |
| Total cash flows from operations | $184.1 | $179.6 | $126.58 | $82.97 |
| Investing activities | ||||
| Capital expenditures | -$5.8 | -$6.18 | -$5.7 | -$4.61 |
| Investments | $36.99 | -$0.24 | -$635.47 | -$38.34 |
| Total cash flows from investing | $31.19 | -$59.92 | -$640.57 | -$70.42 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$264.38 | -$70.64 | $565.21 | $6.88 |
| Net borrowings | ||||
| Total cash flows from financing | -$276.52 | -$74.46 | $560.41 | $5.41 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$61.24 | $45.22 | $46.42 | $17.96 |
News
Fundamentals
| Market cap | $9.73B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 186.78M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.20 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 7.24 |
| Quick ratio | N/A |